By gene editing, the PD-L1 of DC cells was effectively knocked out, the activation and maturation of DC cells were enhanced, and the anti-tumor immune response mediated by T cells was improved, which significantly inhibited the growth of colon cancer in the tumor-bearing mouse model [189]. The gene discussed is CD274; the disease is neoplasm.